VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals was founded in 2004 and is headquartered in San Francisco, California. VIA Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the research and development of compounds for the treatment cardiovascular and metabolic diseases. The company is building a pipeline of small-molecule drugs that target inflammation in the blood vessel wall, an underlying cause of atherosclerosis and its complications, including heart attack and stroke. Its principal product, VIA-2291, is in Phase II clinical trials in patients with acute coronary syndrome and patients with stenosis of the carotid artery. The company has agreements with Hoffmann-LaRoche Inc. and Hoffmann-LaRoche Ltd. to develop and commercialize two sets of compounds for the treatment of cardiovascular and metabolic disease.

Contact Details

Office Address

VIA Pharmaceuticals, Inc.
750 Battery Street, Suite 330
San Francisco, CA, USA 94111
Phone: (415) 283-2200
Fax: (415) 283-2201

Executives

Chief Exec. Officer

Dr. Lawrence K. Cohen

Chief Financial Officer

Mr. James G. Stewart

Business Reviews for VIA Pharmaceuticals, Inc.

Related Companies